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CASE STUDY
AnaConDa™ and Mirus™ for intensive 
care sedation, 24 h desflurane versus  
isoflurane in one patient
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Abstract 
Introduction: With the AnaConDa™ system, inhalational sedation in the intensive care unit has become popular. 
The device can be used with common intensive care unit ventilators and is inserted between the Y-piece and the 
patient. Liquid isoflurane or sevoflurane are delivered by a syringe pump. 90 % of anesthetic exhaled by the patient 
is absorbed by a reflector and resupplied during the next inspiration. The new Mirus™ system also uses a reflector. 
Its control unit identifies end-tidal concentrations from the flow, injects anesthetics during early inspiration, controls 
anesthetic concentrations automatically, and can also apply desflurane. The AnaConDa™ and Mirus™ system are certi-
fied ‘conformité établi’, however, little is known about the Mirus™ and case reports are still lacking.
Case description:  We used the Mirus™ with desflurane for 24 h in a patient suffering from acute respiratory distress 
syndrome. The patient was treated with kinetic lateral rotational therapy. While deeply sedated, our patient breathed 
9.0–12.0 l min−1 spontaneously. Thereafter, awakening and wash-out were considerably shorter than after isoflurane 
in the same patient with AnaConDa™. There were no major problems during the sedation. However, consumption of 
desflurane was high.
Conclusion: Desflurane sedation with the Mirus™ seems promising, but the reflector should be improved to absorb 
and resupply more of the anesthetic agent.
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Introduction
Inhalational sedation in the setting of an intensive care 
unit (ICU) has become popular with the arrival of the 
AnaConDa™ system (Sedana Medical, Uppsala, Swe-
den) (Sackey et  al. 2004). Instead of a circle system, the 
AnaConDa™ uses a specific anesthetic reflector to save 
on the anesthetic agent. A syringe pump delivers liq-
uid isoflurane or sevoflurane into a porous hollow rod 
called “evaporator” (Meiser et al. 2009). No vaporizer and 
no fresh gas flow to carry the anesthetic to the patient 
are needed. The AnaConDa™ can be used with com-
mon intensive care ventilators. The use of anesthesia 
ventilators with circle systems in the intensive care set-
ting is not an option as they are not licensed for stand-
alone use and poorly support spontaneous breathing.
The German sedation guidelines recommend inhala-
tional sedation in patients ventilated via tracheal tube or 
tracheostomy as an alternative to intravenous sedation 
(Baron et al. 2015).
A reflection system with desflurane would be advan-
tageous because of its more favorable kinetics (Bennett 
et  al. 1992; Tsai et  al. 1992) and higher stability com-
pared to sevoflurane (Perbet et  al. 2013; Rohm et  al. 
2009). Desflurane cannot be applied via syringe pump 
as in the AnaConDa™ because of its low boiling point. 
Desflurane needs a special system for vaporization and 
administration.
The new Mirus™ system (Pall Medical, Dreieich, Ger-
many) is the first to use desflurane with anesthetic reflec-
tion instead of a circle system. The new Mirus™ as well 
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as the AnaConDa™ are certified ‘conformité établi’ (CE) 
for the use in the intensive care unit (ICU). Nevertheless, 
there are no existing case reports about the Mirus™; in 
contrast, the AnaConDa™ is well known. Therefore, we 
evaluated the functioning of the Mirus™ in a critically 
ill patient and compared wash-out of desflurane admin-
istered with the Mirus™ with that of isoflurane adminis-
tered with the AnaConDa™ in the same patient.
Case description
A 70-year-old woman, 162 cm tall, weighing 105 kg, suf-
fered from paralytic ileus after surgical removal of an 
abdominal mass. Pathology revealed a follicular non-
Hodgkin lymphoma grade 1–2. After severe aspiration, 
she was admitted to our ward. She was stabilized and her 
trachea was intubated; bronchoscopy confirmed severe 
aspiration of gastric contents. The patient developed 
moderate acute respiratory distress syndrome and was 
treated with kinetic lateral rotational therapy (Rotorest™ 
bed, KCI, San Antonio, Texas, USA).
After approval of the ethics committee (Landesär-
ztekammer des Saarlandes; reference 199/09) and 
informed consent by the legal representative, later con-
firmed by the patient herself, sedation was switched on 
day four from midazolam/sufentanil to desflurane, 3.3–
3.8 vol%, administered with the Mirus™ for 24 h (Fig. 1a). 
Sufentanil was decreased from 0.95 to 0.38 µg kg−1 h−1.
A desflurane specific version of the Mirus™ was con-
nected to an Evita 4 ICU ventilator as prescribed by the 
manufacturer (Fig.  1b). The Mirus™ interface, inserted 
between the Y-piece and the endotracheal tube, con-
sists of two parts: the “Mirus Reflector”, which com-
prises an anesthetic reflector and endings of cables for 
direct gas injection, for measuring pressure, flow, and gas 
Fig. 1 a Mirus™ device. b Setup of the Mirus™ system: the interface (“Mirus™ Exchanger”) is inserted between the Y-piece (1) and the endotracheal 
tube (2). The interface is connected with the control unit by a multi-lumen cable (blue line). An active anaesthesia gas scavenging system (black 
arrow) connected to the vacuum system is provided by the manufacturer. c Setup of the AnaConDa™: the AnaConDa™ is inserted between the 
Y-piece (1) and the endotracheal tube (2). Liquid isoflurane or sevoflurane is administered by a syringe pump into a hollow rod (“Evaporator”). An 
external gas monitor must be used. Active and passive scavenging systems are available and should be connected to the gas outlet of the ventila-
tor (black arrow). Sample gas should also be scavenged. d Wash-out kinetics of desflurane (blue) and isoflurane (purple) over 20 min in the same 
patient after 24-h application. The end-tidal desflurane concentration decreases down to 20 % of the initial concentration (C0; 3.8 vol%) after 1 min; 
the isoflurane concentration only decreases to 50 % of C0 (0.8 vol%) during the whole observation period. The patient first responded after 5.08 min 
at 0.7 vol% desflurane and after 17 min at 0.44 vol% isoflurane
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concentrations; and the “Mirus Filter” for conditioning of 
breathing gas (heat moisture exchanger) and removal of 
bacteria, viruses, and particles.
The control unit displays respiratory pressure and flow 
continuously. The end-tidal desflurane concentration is 
controlled automatically to a set target value. The speed 
of control can be chosen as slow (symbol: tortoise), mod-
erate (symbol: hare), or high (symbol: cheetah), leading 
to higher inspiratory concentrations during wash-in. We 
selected moderate speed of control.
Thereafter, isoflurane, 0.5–0.7  vol%, was applied with 
the AnaConDa™ and the Vamos gas monitor. Setup was 
according to the manufacturer’s instructions (Fig.  1c). 
Liquid isoflurane was delivered by a syringe pump (Per-
fusor fm; Braun Melsungen AG, Germany). The same 
Evita 4 ICU ventilator and the same ventilator accessories 
were used.
End-tidal concentrations, the bispectral index (BIS™, 
Aspect Medical Systems, Newton, MA, USA) and the 
Richmond Agitation and Sedation Scale (RASS) score 
were recorded manually once every hour.
During gas application with both systems, RASS scores 
were between -4 and -5 and the bispectral index between 
35 and 55. While deeply sedated, our patient breathed 
9.0–12.0  l  min−1 spontaneously. There were no major 
problems during the sedation, no relevant increase in 
arterial carbon dioxide tension, and no relevant changes 
in hemodynamics. During 24-h sedation with the 
Mirus™, 1261 ml desflurane were consumed as opposed 
to 96 ml isoflurane per 24 h with the AnaConDa™.
In two sedation windows, after 24  h desflurane and 
24 h isoflurane respectively, wash-out of both gases was 
recorded with the Vamos gas monitor. The Mirus™ inter-
face and the AnaConDa™ respectively were replaced 
by a heat moisture exchanger with a gas sampling port 
(Humid-Vent Filter Compact S, Teleflex Medical GmbH, 
Kernen, Germany). Sedation recovery was monitored by 
an observer calling the patient’s name every 30 s.
Wash-out of desflurane after 24  h was consider-
ably shorter than that of isoflurane. With the Mirus™, we 
observed the patient’s first response 5.08  min after stop-
ping desflurane at an end-tidal concentration of 0.7 vol% 
as opposed to 17 min after stopping isoflurane at a concen-
tration of 0.4 vol% using the AnaConDa™ system (Fig. 1d).
Oxygenation improved under lateral rotational therapy 
(from day 4 until day 12 after ICU admission). Until day 
12, the patient was sedated with the AnaConDa™ (Iso-
flurane), and thereafter with sufentanil and bolus doses 
of midazolam. Invasive ventilation was continued inter-
mittently until day 29; the patient was transferred to the 
ward on day 68 and discharged to a rehabilitation center 
on day 87.
Discussion
Overall, sedation of our patient with desflurane and the 
Mirus™ during 24 h was completely satisfactory. Using a 
low opioid dose, spontaneous breathing was possible in 
a patient deeply sedated to avoid unpleasant perceptions 
during kinetic lateral rotational therapy. In compari-
son with isoflurane and the AnaConDa™, we observed a 
comparable sedation quality, however, wash-out of des-
flurane and awakening were considerably shorter. Still, 
the Mirus™ reflector should be improved to save more 
anesthetics.
In view of the better kinetics of desflurane with 
known shorter wash-out time (Juvin et al. 1997; Bailey 
1997), this is not surprising. However, this is the first 
report on wash-out of desflurane and isoflurane after 
such a long exposure time, starting from rather low 
concentrations in a critically ill patient. As the patient 
served as her own control, and the difference may be 
expected from the kinetics, our results are reliable and 
underline the magnitude of the difference: not only was 
the time to first response 5  min versus seventeen but 
isoflurane concentration quickly declined to about 50 % 
of the initial concentration and then remained stable 
because of redistribution from poorly perfused tissues. 
Desflurane concentration declined to 20  % of the ini-
tial concentration and continued to decline thereafter, 
which implies that there was very little accumulation. 
This should be considered an advantage in itself, as the 
patient will not only respond to verbal commands but 
regain higher cognitive functions far quicker than after 
isoflurane.
Kinetic lateral rotational therapy needs deep sedation 
to avoid unpleasant perceptions. However, deep intra-
venous sedation is associated with severe respiratory 
depression necessitating mechanical ventilation. Patients 
suffering from acute respiratory distress syndrome ben-
efit from spontaneous breathing. Using isoflurane or 
desflurane and a low opioid dose, spontaneous breathing 
is possible in a patient deeply sedated. Moreover, long-
term deep intravenous sedation has been associated 
with an increased mortality (Shehabi et al. 2013). In con-
trast, long-term isoflurane sedation seems to avoid this 
increase in mortality (Bellgardt et al. 2016).
With the AnaConDa™, an external gas monitor must be 
used. This monitor will erroneously display early inspira-
tory peak concentrations as end-tidal. This phenomenon 
has been described by our group (Meiser and Laubenthal 
2005). In contrast, the Mirus™ comprises its own moni-
tor for gas concentration, pressure, and flow measure-
ments. Unlike other monitors, the Mirus™ assigns the 
concentration measurements to the phases of the respira-
tory cycle not depending on carbon dioxide but on the 
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flow. Obviously, the time lag associated with side stream 
gas measurements must be taken into account.
In our previous bench study, we found a high accuracy 
and precision of the end-tidal concentrations displayed 
by the Mirus™ (Bomberg et al. 2014). However, there was 
a swing of 20  % around the target concentration with a 
periodicity of 2.6  min which may be criticized. In our 
patient, we did not see oscillations in the bispectral index 
or any clinical signs of an alternating sedation level.
In our previous bench study, mean inspiratory concen-
trations during desflurane injections were only 134 % (SD 
12 %) of the preceding end-tidal concentration (Bomberg 
et al. 2014). This is unlikely to elicit sympathetic activa-
tion as described in the literature (Ebert et  al. 1998; 
Weiskopf et  al. 1994). In our patient, we did not notice 
sympathetic activation during washing-in of desflurane.
However, consumption of desflurane was high. Also, 
with the AnaConDa™, consumption of isoflurane and 
sevoflurane was very high in the beginning (Enlund et al. 
2001). With technical modifications of the reflector, this 
could be improved (Meiser et al. 2009).
For 24-h sedation with 3.5  vol% desflurane on aver-
age, 1261 ml desflurane were consumed. In our previous 
bench study (Bomberg et  al. 2014), by a simple modifi-
cation of the Mirus™ anaesthetic reflector, we could cut 
consumption in half. Given a six times higher potency of 
isoflurane, 600  ml of desflurane consumed would seem 
reasonable compared to 100 ml isoflurane.
During the application, only two minor problems 
occurred. First, filling of the desflurane reservoir with a 
capacity of 250  ml took more than 120  s. Secondly, the 
volume expansion by injection of desflurane repeatedly 
triggered alarms of the ventilator because the ventilator 
measured a higher expired than inspired tidal volume. 
Deactivation of the flow sensor may be admissible as the 
Mirus™ also measures and displays respiratory param-
eters. However, staff must be instructed about this.
Our favorable result is in line with two older reports 
on desflurane sedation (Sharpe et al. 2002; Meiser et al. 
2003). Desflurane sedation with the Mirus™ system 
should be tested in randomized controlled trials focusing 
on feasibility, sedation control, and outcome parameters.
Conclusion
Our findings imply that Mirus™ is a useful, unique sys-
tem for administration of desflurane with common inten-
sive care ventilators. Spontaneous breathing is possible in 
a patient deeply sedated, and awakening after desflurane 
is considerably shorter compared to isoflurane.
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